NANJING, China, Sept. 3, 2020 /PRNewswire/ -- InxMed (Nanjing) Co., Ltd. ("InxMed" or "Company"), a clinical stage biotech company dedicated to developing innovative, individualized medicines with international impact, today announced the completion of its Series A+ financing of 130M RMB...
SHANGHAI, Sept. 3, 2020 /PRNewswire/ -- The Hotel Plus 2020, hosted by Shanghai Sinoexpo Informa Markets, concluded with great success at National Exhibition and Convention Centre (NECC) in Shanghai, China from 12th – 14th August. Over the 3-day period, the show was packed with more than...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]newswire.com:443/news-releases